Bio-Gate: Update on the HIPrevision clinical trial for HyProtect™-coated hip revision implants Study protocol published in the internationally recognized peer-reviewed journal Trials (Springer Nature/BMC) Multicenter, …
WeiterlesenBio-Gate strengthens its presence in North America with increased sales of animal care products to veterinarians and pet owners Product launch of new animal care …
WeiterlesenBio-Gate offers effective infection prevention in human medicine with HyProtectTM technology Project partner launches study for CE approval of implants coated with HyProtectTM Unique selling …
WeiterlesenBio-Gate AG signs LOI with North American medical device manufacturer for trauma implants Nürnberg, July 31, 2023 – Bio-Gate AG (ISIN DE000BGAG981), one of the …
WeiterlesenBio-Gate strengthens presence in the North American market for innovative animal care Bio-Gate’s customer launches a new product line for ear infections Technological leadership in …
Weiterlesen